Skip to content
Dr. Christopher Wall, Metabolic Health

Dr. Christopher Wall

Co-Founder, Co-CEO and Chief Scientific Officer of Maven Health

Maven Health

Co-Founder, Co-CEO & CSO, Maven Health · Zurich chapter

Christopher Wall, PharmD, PhD, is the Co-Founder, Co-CEO and Chief Scientific Officer of Maven Health, where he leads the scientific development of a saliva-based metabolomics platform for non-invasive metabolic assessment.

Highlights

  • Co-founded Maven Health (EPFL spinout) with data scientist Kevin Hof; the company quantifies metabolites from saliva using NMR spectroscopy and machine learning for non-invasive metabolic assessment.
  • Secured a CHF 100,000 EPFL FIT Innogrant (January 2024) plus pre-seed backing from S2S Ventures.
  • Closed a strategic seed round (April 2025) with the Founderful Campus Fund, S2S Ventures and an NMR laboratory partner.
  • PhD in mitochondrial biology at EPFL (2021); doctoral thesis on mitochondrial respiratory chain dysfunction and cellular cholesterol homeostasis; pharmacist by training (Utrecht University).
  • Expanded Maven Health to the Netherlands and launched in the UK & Ireland (2025) in partnership with Regenerus Laboratories.

Co-founded Maven Health (EPFL spinout) with data scientist Kevin Hof; the company quantifies metabolites from saliva using NMR spectroscopy and machine learning for non-invasive metabolic assessment.. Secured a CHF 100,000 EPFL FIT Innogrant (January 2024) plus pre-seed backing from S2S Ventures.. Closed a strategic seed round (April 2025) with the Founderful Campus Fund, S2S Ventures and an NMR laboratory partner.. PhD in mitochondrial biology at EPFL (2021); doctoral thesis on mitochondrial respiratory chain dysfunction and cellular cholesterol homeostasis; pharmacist by training (Utrecht University).. Expanded Maven Health to the Netherlands and launched in the UK & Ireland (2025) in partnership with Regenerus Laboratories..

About Christopher Wall

Christopher Wall is the co-founder, co-CEO and Chief Scientific Officer of Maven Health, a Lausanne-based EPFL spinout developing non-invasive saliva-based metabolomics for clinics, nutritionists and functional-medicine practitioners. He was originally trained as a pharmacist at Utrecht University and completed his PhD specialising in mitochondrial functions at EPFL in 2021.

Wall co-founded Maven Health with data scientist Kevin Hof. The company's core product is a saliva-based metabolite-measurement protocol and an insights platform that turns metabolomic data into actionable recommendations. Maven received a CHF 100,000 FIT Innogrant from EPFL in January 2024 and pre-seed funding from S2S Ventures.

In 2025 Maven launched its UK and Ireland rollout in partnership with Regenerus Laboratories and published a whitepaper on the metabolic effects of the Eat by Alex ReSet programme. According to his co-founder, Maven placed second in the public vote of the MedTech category at the TOP 100 Swiss Startup Award 2025. His scientific identity is rooted in cellular metabolism and mitochondrial biology.

Credentials

  • PhDPhD (Mitochondrial Biology)— EPFL(2021)
  • OtherPharmacist (training)— Utrecht University

Education

Awards

  • EPFL FIT Innogrant (CHF 100,000) — EPFL (2024)

Topics & Expertise

Talks at Longevity USA

Past

  • Human 2.0 - Biohacking Workshop — Apr 23, 2026 · ETH (Clausiusstrasse 16, 8006 Zurich

Frequently Asked

Who is Christopher Wall?

Christopher Wall is the co-founder, co-CEO and Chief Scientific Officer of Maven Health, an EPFL spinout developing non-invasive saliva-based metabolomics. He holds a PhD in mitochondrial biology from EPFL (2021) and was originally trained as a pharmacist at Utrecht University.

What does Maven Health do?

Maven Health, co-founded by Christopher Wall, measures metabolites from a saliva sample using NMR spectroscopy and turns the data into actionable nutrition and metabolic-health recommendations. It works on a B2B2C model with nutritionists, general practitioners, pharmacies and clinics.

What technology does Maven Health use?

Maven Health uses nuclear magnetic resonance (NMR) spectroscopy combined with a proprietary software platform and machine-learning algorithms to quantify metabolites in saliva, offering a non-invasive alternative to blood-based testing.

What are Christopher Wall's credentials?

Christopher Wall holds a PhD in mitochondrial biology from EPFL (2021), where his doctoral research addressed mitochondrial respiratory chain dysfunction and cellular cholesterol homeostasis. He was originally trained as a pharmacist at Utrecht University.

Who founded Maven Health?

Maven Health was founded in 2024 by Christopher Wall and data scientist Kevin Hof as an EPFL spinout. Wall serves as co-CEO and Chief Scientific Officer, leading the scientific development of the saliva-metabolomics platform.